Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
about
Stable dry powder formulation for nasal delivery of anthrax vaccineMass spectrometric approaches to study protein structure and interactions in lyophilized powders.Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.Nebulization as a delivery method for mAbs in respiratory diseases.Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.Predicting protein aggregation during storage in lyophilized solids using solid state amide hydrogen/deuterium exchange with mass spectrometric analysis (ssHDX-MS)Higher impact energy in traumatic brain injury interferes with noncovalent and covalent bonds resulting in cytotoxic brain tissue edema as measured with computational simulation.Effect of pH and excipients on structure, dynamics, and long-term stability of a model IgG1 monoclonal antibody upon freeze-drying.Optimization and characterization of spray-dried IgG formulations: a design of experiment approach.Swelling lecithin: cholesterol implants for the controlled release of proteins.Effects of Drying Process on an IgG1 Monoclonal Antibody Using Solid-State Hydrogen Deuterium Exchange with Mass Spectrometric Analysis (ssHDX-MS).Lysozyme-lysozyme self-interactions as assessed by the osmotic second virial coefficient: impact for physical protein stabilization.Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals
P2860
Q28386405-0A19601D-3B98-4A39-A7DE-8875EF49B8C4Q30374347-14A67213-1104-4568-9283-8D11C1CC2E4AQ36301885-C606F2F6-1A21-45AC-BEFE-7CA6791DE34CQ37164218-FAC77E1D-BEA5-403C-BDD6-6466402ED1BAQ38125505-17CA747F-A33F-4CB3-9CFF-A86F6325917FQ38306677-6DC9B804-7E21-467D-9D55-5146E0A72944Q40119636-6AF2FB82-6534-47CB-A48E-350677D01B77Q40505241-8C656D15-9DFA-4F6E-BE0C-3A935EFA4950Q41428170-0A1374AB-C84F-4766-828A-7FBA8BC98A53Q44128392-F09DFDE1-D33B-47D6-814A-F10024627EE0Q45796035-BA1CF911-FBD9-4A04-8BAC-5F615241E254Q45974642-7CC786D8-5462-43CB-AA3C-A43DF3707870Q47233598-689664E4-0A16-41E0-99BC-55A826FE1133Q51814600-C0CE4DE8-930D-4C2A-AE6C-82EA5475A2B5Q58767550-7068A376-E3BE-4303-B137-E7FC52C0CC45
P2860
Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Conformational analysis of pro ...... ntibody/mannitol formulations.
@ast
Conformational analysis of pro ...... ntibody/mannitol formulations.
@en
type
label
Conformational analysis of pro ...... ntibody/mannitol formulations.
@ast
Conformational analysis of pro ...... ntibody/mannitol formulations.
@en
prefLabel
Conformational analysis of pro ...... ntibody/mannitol formulations.
@ast
Conformational analysis of pro ...... ntibody/mannitol formulations.
@en
P2093
P1476
Conformational analysis of pro ...... ntibody/mannitol formulations.
@en
P2093
Karoline Bechtold-Peters
Patrick Garidel
Stefanie Schüle
Wolfgang Friess
P356
10.1016/J.EJPB.2006.08.014
P407
P577
2006-09-01T00:00:00Z